Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has reported a significant improvement in its half-year results, with revenue from contracts with customers seeing a 65% increase and profits after tax turning positive. The company, which had suffered losses in the previous corresponding period, has now posted a comprehensive profit. No dividends have been proposed or paid, and the report suggests no commitments to future dividend levels or franking credits.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
